Clinical studies have suggested that pharmacological inhibition on RAS is a critical component in the treatment of hypertension, in which the ACE inhibitors and Angiotensin 2 receptor blockers are the effective and most commonly used agents [26, 27]. This evidence concerns the gene ACE and Hypertension.